IFG Advisory’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $202K | Buy |
497
+73
| +17% | +$29.6K | 0.01% | 719 |
|
|
2025
Q1 | $211K | Buy |
424
+5
| +1% | +$2.49K | 0.01% | 645 |
|
|
2024
Q4 | $218K | Buy |
+419
| New | +$218K | 0.01% | 627 |
|
|
2024
Q3 | – | Sell |
-397
| Closed | -$220K | – | 596 |
|
|
2024
Q2 | $220K | Buy |
+397
| New | +$220K | 0.01% | 568 |
|
|
2024
Q1 | – | Sell |
-414
| Closed | -$220K | – | 559 |
|
|
2023
Q4 | $220K | Buy |
+414
| New | +$220K | 0.02% | 539 |
|
|
2023
Q2 | – | Sell |
-489
| Closed | -$282K | – | 480 |
|
|
2023
Q1 | $282K | Buy |
489
+55
| +13% | +$31.7K | 0.03% | 420 |
|
|
2022
Q4 | $239K | Sell |
434
-384
| -47% | -$211K | 0.02% | 433 |
|
|
2022
Q3 | $414K | Buy |
818
+301
| +58% | +$152K | 0.04% | 349 |
|
|
2022
Q2 | $281K | Sell |
517
-18
| -3% | -$9.78K | 0.03% | 387 |
|
|
2022
Q1 | $316K | Sell |
535
-96
| -15% | -$56.7K | 0.03% | 387 |
|
|
2021
Q4 | $421K | Buy |
631
+18
| +3% | +$12K | 0.04% | 335 |
|
|
2021
Q3 | $350K | Buy |
613
+16
| +3% | +$9.14K | 0.04% | 364 |
|
|
2021
Q2 | $301K | Buy |
597
+52
| +10% | +$26.2K | 0.03% | 391 |
|
|
2021
Q1 | $248K | Sell |
545
-34
| -6% | -$15.5K | 0.03% | 428 |
|
|
2020
Q4 | $269K | Buy |
579
+103
| +22% | +$47.9K | 0.04% | 374 |
|
|
2020
Q3 | $210K | Buy |
+476
| New | +$210K | 0.03% | 388 |
|